Market Research Logo

Global Female Contraceptives Market 2015-2019

About female contraceptive

Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.

Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.This report covers the following types of female contraceptive:Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)Drugs (Birth control pills and Emergency pills)

Technavio's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

AmericasAPACEMEA

Key vendors

AllerganMerckPfizerTeva Pharmaceutical

Other prominent vendors

AnsellChurch & DwightBayerAgile TherapeuticsCayaFuji LatexJanssen PharmaceuticalsHLL LifecareLipocineMayer LaboratoriesOkamoto IndustriesReckitt Benckiser GroupToday SpongeFemale Health

Key market driver

Improved family planningFor a full, detailed list, view our report

Key market challenge

Lack of social acceptanceFor a full, detailed list, view our report

Key market trend

Increased unplanned pregnancyFor a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Female Contraceptives Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Female Contraceptives Market: Allergan, Merck, Pfizer and Teva Pharmaceutical

Other Prominent Vendors in the market are: Ansell, Church & Dwight, Bayer, Agile Therapeutics, Caya, Fuji Latex, Janssen Pharmaceuticals, HLL Lifecare, Lipocine, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser Group, Today Sponge and Female Health

Commenting on the report, an analyst from Technavio’s team said: “New contraceptives methods such as subdermal progestin implants, vaginal contraceptive rings, transdermal patches, and third-generation oral contraceptives are being increasing used by consumers. The market share for these methods is likely to increase during the forecast period, owing to their increased safety, convenience, and benefits. In addition, the development of MPTs that prevent both pregnancy and STIs are increasing.”

According to the report, the high demand for pills, the cheapest, easiest, and safest means of contraception, among individuals is driving the market.

Further, the report states that societal norms related to intimacy are discouraging consumers from openly buying these products, thereby hindering market growth.

Companies Mentioned

Allergan, Merck, Pfizer, Teva Pharmaceutical, Ansell, Church & Dwight, Bayer, Agile Therapeutics, Caya, Fuji Latex, Janssen Pharmaceuticals, HLL Lifecare, Lipocine, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser Group, Today Sponge,Female Health

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Table Global female contraceptives market 2014-2019 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • Global female contraceptives market by type
      • Table Global female contraceptives market by type 2014 and 2019
      • Table Global female contraceptives market by type 2014-2019 ($ millions)
      • Table Global female contraceptives market by type 2014-2019
    • Global female contraceptive devices market
      • Table Global female contraceptives market by devices 2014-2019 ($ millions)
      • Table Global female contraceptive devices market by type 2014 and 2019
    • Global IUDs market
      • Table Global IUD's market 2014-2019 ($ millions)
    • Global sterilization market
      • Table Global sterilization market 2014-2019 ($ millions)
    • Global subdermal contraceptive implants market
      • Table Global subdermal contraceptive implants market 2014-2019 ($ millions)
    • Global vaginal rings market
      • Table Global vaginal rings market 2014-2019 ($ millions)
    • Global female condoms market
      • Table Global female condoms market 2014-2019 ($ millions)
    • Global non-surgical permanent contraceptive devices market
      • Table Global non-surgical permanent contraceptive devices market 2014-2019 ($ millions)
    • Global contraceptive diaphragms market
      • Table Global contraceptive diaphragms market 2014-2019 ($ millions)
    • Global contraceptive sponges market
      • Table Global contraceptive sponges market2014-2019 ($ millions)
    • Global female contraceptive drugs market
      • Table Global contraceptive drugs by product type
      • Table Global female contraceptive drugs market 2014-2019 ($ millions)
      • Table Global female contraceptives drugs market by type
    • Global birth control pills market
      • Table Global birth control pills market 2014-2019 ($ millions)
    • Global emergency pills market
      • Table Global emergency pills market 2014-2019 ($ millions)
  • Market segmentation by region
    • Table Global female contraceptives by region 2014-2019
    • Female contraceptives market in Americas
      • Table Female contraceptive market in Americas 2014-2019 ($ millions)
    • Female contraceptives market in EMEA
      • Table Female contraceptives market in EMEA 2014-2019 ($ millions)
    • Female contraceptives market in APAC
      • Table Female contraceptive market in APAC 2014-2019 ($ millions)
  • Market drivers
    • Table Effectiveness of female contraception by type
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Unplanned pregnancies by region 2014-2019 ($ millions)
    • Table Population of women using birth pill for non-contraceptive reasons (%)
  • Vendor landscape
    • Vendor investment opportunity
      • Table Vendor investment opportunity
  • Analysis of other key vendors
  • Key vendor analysis
    • Allergan
      • Table Allergen: Business segmentation 2014
      • Table Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
    • Merck
    • Pfizer
      • Table Pfizer: Business segmentation 2014
      • Table Pfizer: Geographical segmentation 2014
    • Teva Pharmaceuticals
      • Table Teva Pharmaceuticals: Business segmentation 2014
      • Table Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Teva Pharmaceuticals: Geographical segmentation 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report